Autolus Therapeutics PLC reports results for the quarter ended in June - Earnings Summary

Autolus Therapeutics

03/08/2023 14:33

* Autolus Therapeutics PLC  AUTL.OQ  reported a quarterly
adjusted
loss of 26 cents​​ per share for the quarter ended in June. The
mean expectation of eight analysts for the quarter was for a
loss of 22 cents per share.
    * Reported revenue was zero​; analysts expected $136.50
thousand. 
    * Autolus Therapeutics PLC's reported EPS for the quarter
was a
loss of 26 cents​.
    * The mean earnings estimate of analysts had risen by
about 10.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Autolus Therapeutics PLC shares had risen by 31.5% this
quarter and gained 64.7% so far this year.
    * The company reported a quarterly loss of $45.55 million.
    * Wall Street's median 12-month price target for Autolus
Therapeutics PLC is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 01:33 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.22          -0.26          Missed
 Mar. 31 2023      -0.27          -0.23          Beat
 Dec. 31 2022      -0.27          -0.23          Beat
 Sep. 30 2022      -0.46          -0.47          Missed